Search
Polaryx Therapeutics Ord Shs
PLYXAdd to Watchlist
2.670USD
-0.740-21.70%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
126.41MMarket Cap
LossP/E TTM
More Details of Polaryx Therapeutics Ord Shs Company
Polaryx Therapeutics Ord Shs Info
Ticker SymbolPLYX
Company namePolaryx Therapeutics Inc
IPO dateFeb 02, 2026
CEOYang (Alex Keun Mo)
Number of employees- -
Security typeOrdinary Share
Fiscal year-end- -
Address- -
City- -
Stock exchangeNASDAQ OMX - NASDAQ BASIC
Country- -
Postal code- -
Phone- -
Website- -
Ticker SymbolPLYX
IPO dateFeb 02, 2026
CEOYang (Alex Keun Mo)
Company Executives of Polaryx Therapeutics Ord Shs
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Mr. Alex Yang, J.D.
Mr. Alex Yang, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Lisa L. Bollinger, M.D.
Dr. Lisa L. Bollinger, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. G. Michael Landis, CPA
Mr. G. Michael Landis, CPA
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Andrew O
Mr. Andrew O
Chief Investment Officer
Chief Investment Officer
--
--
Dr. Mitchel Berger, M.D.
Dr. Mitchel Berger, M.D.
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Francis A. Braun
Mr. Francis A. Braun
Independent Director Nominee
Independent Director Nominee
--
--
Dr. Charles S. Ryan, J.D., Ph.D.
Dr. Charles S. Ryan, J.D., Ph.D.
Independent Director Nominee
Independent Director Nominee
--
--
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Mr. Alex Yang, J.D.
Mr. Alex Yang, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Lisa L. Bollinger, M.D.
Dr. Lisa L. Bollinger, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. G. Michael Landis, CPA
Mr. G. Michael Landis, CPA
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Andrew O
Mr. Andrew O
Chief Investment Officer
Chief Investment Officer
--
--
Dr. Mitchel Berger, M.D.
Dr. Mitchel Berger, M.D.
Independent Director Nominee
Independent Director Nominee
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Mstone Partners Healthcare Ltd
48.04%
Koh (Gershon)
11.67%
Rush University Medical Center
8.04%
Young Poong Pharmaceutical Co, Ltd.
5.24%
The Vanguard Group, Inc.
3.52%
Other
23.49%
Shareholders
Shareholders
Proportion
Mstone Partners Healthcare Ltd
48.04%
Koh (Gershon)
11.67%
Rush University Medical Center
8.04%
Young Poong Pharmaceutical Co, Ltd.
5.24%
The Vanguard Group, Inc.
3.52%
Other
23.49%
Shareholder Types
Shareholders
Proportion
Corporation
61.32%
Individual Investor
11.68%
Investment Advisor
7.28%
Investment Advisor/Hedge Fund
0.30%
Other
19.41%
Institutional Shareholding
Updated: Fri, May 1
Updated: Fri, May 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
6
3.59M
7.58%
+3.59M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Mstone Partners Healthcare Ltd
22.74M
48.04%
+22.74M
--
Feb 02, 2026
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
